USPTO serial 50024662
KRINGLE PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with KRINGLE PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Osaka-shi, Osaka, JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kumiko Ide
Kumiko Ide WENDEROTH, LIND & PONACK, LLP1150 Connecticut Avenue, NW, Suite 505Washington, DC 20036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations for the treatment of liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases, cancer; pharmaceutical preparations acting on the peripheral nervous system; cardiovascular treatment preparations; capillary stabilizers, namely, pharmaceutical preparations for stabilizing capillaries; cerebral hemorrhage prophylactic preparations; pharmaceutical preparations acting on respiratory organs for treating respiratory illnesses and conditions; pharmaceutical preparations acting on digestive organs for treating ulcers and digestive conditions; pharmaceutical preparations for dental purposes for treating and preventing gingivostomatitis, alveolar abscess, and alveoloclasia; pharmaceutical preparations acting on uro-genital and anal organs for treating urinary and anal gland related illnesses and conditions; medicated skin care preparations; astringents for medical purposes; anti-inflammatory agents; saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, and lupus erhthematosus; hemostatics for medical purposes; pharmaceutical preparations affecting metabolism; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for treating physically caused lesions; radiation sickness treating drugs; pharmaceutical preparations for treating chemically caused disorders, namely, for treating chemical burns, side effects of anticancer drugs, and side effects of immunosuppresants; biological preparations for medical purposes, namely, biological tissue grafts | ACTIVE | — |
| 042 | Testing, inspection or research of pharmaceuticals and genetics; medical research; consultancy and providing testing, inspection and research information services in the field of testing, inspection or research of pharmaceuticals and genetics; consultancy and providing research information services in the field of medical research; providing medical research and scientific research information and advice in the fields of pharmaceuticals and genetics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 31, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 31, 2026 | NWAP | NEW APPLICATION ENTERED | — |